Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study
HCM is associated with decreased QoL and increased societal costs, especially in younger and symptomatic patients. oHCM patients were more frequently symptomatic than nHCM patients. This study highlights the substantial disease burden of HCM and can aid in assessing new therapy cost-effectiveness for HCM in the future.
Authors
- Stephan A C Schoonvelde (ORCID: https://orcid.org/0000-0001-6235-016X)
- Silvia Evers (ORCID: https://orcid.org/0000-0003-1026-570X)
- Judith M.A. Verhagen (ORCID: https://orcid.org/0000-0002-0340-3433)
- M. Hiligsmann
- Michelle Michels (ORCID: https://orcid.org/0000-0001-6432-0431)
- Arend F. L. Schinkel (ORCID: https://orcid.org/0000-0002-6424-0754)
- Rudolf A. de Boer (ORCID: https://orcid.org/0000-0002-4775-9140)
- Isabell Wiethoff (ORCID: https://orcid.org/0000-0002-2608-2900)
- Peter-Paul Zwetsloot (ORCID: https://orcid.org/0000-0002-2634-4667)
- Maurits A. Sikking (ORCID: https://orcid.org/0000-0001-8165-6631)
- Marjon A. van Slegtenhorst
- Christian Knackstedt (ORCID: https://orcid.org/0000-0002-5457-3010)
- Alexander Hirsch (ORCID: https://orcid.org/0000-0002-3315-2006)
- Tjeerd Germans (ORCID: https://orcid.org/0000-0003-2781-0145)
Institutions
- Maastricht University Medical Centre (NL)
- Erasmus MC (NL)
- Maastricht University (NL)
- Northwest Hospital (US)
- Netherlands Heart Institute (NL)
- Department of Health (TW)
- Trimbos Institute (NL)
- Department of Health Services (NP)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- European Heart Journal - Quality of Care and Clinical Outcomes
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1093/ehjqcco/qcae092
- Citations
- 14
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.63
Funders
- Bristol-Myers Squibb